Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioplastics01:27

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Statin Prescribing for People Living With HIV: A Quality Improvement Initiative.

JACC. Case reports·2026
Same author

Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolution.

Nature communications·2026
Same author

Ethnicity and its impact on presentation and outcomes in patients with spontaneous coronary artery dissection from the Australian-New Zealand registry.

Heart (British Cardiac Society)·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

Vaginal mucosal melanoma recurrence with intracardiac metastasis treated with immunotherapy.

Gynecologic oncology reports·2026
Same author

Health-Related Quality-of-Life and its Determinants After Acute Coronary Syndrome Caused by Spontaneous Coronary Artery Dissection.

Heart, lung & circulation·2026

Related Experiment Video

Updated: May 12, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
11:01

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention

Published on: September 18, 2015

New generation coronary stent technology--is the future biodegradable?

Anthony M Sammel1, Daniel Chen, Nigel Jepson

  • 1Department of Cardiology and Eastern Heart Clinic, Prince of Wales Hospital, Australia. tsammel@hotmail.com

Heart, Lung & Circulation
|April 4, 2013
PubMed
Summary

New drug-eluting coronary stents aim to enhance safety and efficacy. However, current evidence does not show superiority over existing stents, necessitating large, long-term trials.

More Related Videos

4D Printed Bifurcated Stents with Kirigami-Inspired Structures
06:52

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

Published on: July 25, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
11:01

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention

Published on: September 18, 2015

4D Printed Bifurcated Stents with Kirigami-Inspired Structures
06:52

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

Published on: July 25, 2019

Area of Science:

  • Cardiovascular medicine
  • Biomaterials science
  • Interventional cardiology

Background:

  • Drug-eluting stents (DES) are crucial in treating coronary artery disease.
  • Current DES utilize durable polymers and persistent metallic scaffolds, posing long-term limitations.
  • Innovations include non-polymeric, biodegradable polymer-coated stents, and fully biodegradable scaffolds.

Purpose of the Study:

  • To evaluate the clinical performance of novel coronary stent technologies.
  • To assess the potential of new stent designs to overcome limitations of current DES.
  • To determine if next-generation stents offer improved long-term safety and efficacy.

Main Methods:

  • Review of ongoing clinical trials and clinical practice introductions of new coronary stent technologies.
  • Analysis of stent designs focusing on polymer composition (durable vs. biodegradable) and scaffold material (metallic vs. biodegradable).
  • Assessment of study endpoints related to long-term safety and efficacy compared to existing second-generation DES.

Main Results:

  • A new generation of coronary stents, including non-polymeric, biodegradable polymer-coated, and fully biodegradable scaffolds, are under evaluation.
  • These novel devices are designed to enhance long-term safety and efficacy by addressing limitations of durable polymers and metallic scaffolds.
  • Currently, no new stent technology has convincingly demonstrated superiority over established second-generation drug-eluting stents.

Conclusions:

  • Next-generation coronary stents represent significant technological advancements.
  • Despite design innovations, convincing evidence of superiority over current second-generation drug-eluting stents is lacking.
  • Large-scale, long-term randomized controlled trials are essential to validate the clinical benefits of these new stent technologies.